Analyst Ratings for Revance Therapeutics
Analysts have provided the following ratings for Revance Therapeutics (NASDAQ:RVNC) within the last quarter: Bullish Somewhat Bullish Indifferent…
Discontinuation Of Opul Business Weighs On Botox Rival Revance Therapeutics: Analyst Sees Non-Cash Impairment Charge In Millions
Needham analyst Serge Belanger reiterated a Buy rating on Revance Therapeutics, Inc. (NASDAQ: RVNC),
Pinterest To Rally Around 45%? Here Are 10 Other Analyst Forecasts For Wednesday
Rosenblatt increased the price target for Pinterest, Inc. (NYSE: PINS) from $35 to $38. Rosenblatt analyst Barton Crockett maintained a Buy rating. Pinterest shares rose 3.2% to close at $26.21 on Tuesday.
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday.
The Latest Analyst Ratings for Revance Therapeutics
Analysts have provided the following ratings for Revance Therapeutics (NASDAQ:RVNC) within the last quarter: Bullish Somewhat Bullish Indifferent…
Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.
Dow Falls 150 Points; AutoZone Earnings Top Views
U.S. stocks traded lower toward the end of trading, with the Dow Jones falling more than 150 points on Tuesday.
The Dow traded down 0.48% to 34,457.36 while the NASDAQ fell 0.28% to 13,672.29. The S&P 500 also fell, dropping, 0.34% to 4,438.52.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 275 companies made new 52-week lows.